Organovo trading halted, news pending

Written by Emily J. Thompson, Senior Investment Analyst

ONVO%

Source: Business Insider

Updated: Mar 20 2025

0mins

Source: Business Insider

Trading Halt: Organovo (ONVO) has had its trading halted due to pending news, indicating potential significant developments for the company.
Corporate Actions: The company announced a 1-for-12 reverse stock split and is set to be acquired by Eli Lilly, which will expand Eli Lilly's IBD pipeline with Organovo’s FXR program.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Organovo trading halted, news pending

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Vistagen Therapeutics Faces Class Action Lawsuit with Deadline for Lead Plaintiff by March 16, 2026

Monero (XMR) Surges 44% in Five Days, Yet Investment Risks Persist

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch